LINC02313

Across TCGA pan-cancer cohorts, LINC02313 RNA differs between tumor and matched normal tissue in 13 of 18 cancer types tested, making tumor–normal expression one of LINC02313’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC02313 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02313 is over-expressed in tumor, although a few such as KICH and THCA show the opposite, repressed pattern.

KIRC, LIHC, and LUAD are the cancer types where LINC02313 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02313 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	All	+0.962	<.001	11	view →
LIHC	Male	All	+0.899	<.001	8	view →
LUAD	All	II,III,IV	+0.779	<.001	8	view →
KICH	All	II,III,IV	−0.490	<.001	8	view →
KIRP	All	All	+1.151	<.001	7	view →
STAD	All	II,III,IV	+0.925	.003	6	view →
THCA	All	II,III,IV	−0.106	.005	5	view →
COAD	Male	All	+0.651	.018	4	view →
LUSC	Male	All	+0.370	<.001	4	view →
ESCA	All	All	+1.092	.038	2	view →
CHOL	All	All	+1.076	.008	2	view →
UCEC	All	IV	−0.685	.011	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 13 lineages.

LINC02313–KIRC

Open the KIRC breakdown →